Role of Heme in Intracellular Trafficking of Thyroperoxidase and
Involvement of H2O2 Generated at the Apical
Surface of Thyroid Cells in Autocatalytic Covalent Heme Binding*
Laurence
Fayadat
,
Patricia
Niccoli-Sire,
Jeanne
Lanet, and
Jean-Louis
Franc§
From INSERM U 38, Université de la Méditerranée,
Faculté de Médecine, 27 Bd. J. Moulin,
Cedex 5, 13385 Marseille, France
 |
ABSTRACT |
Thyroperoxidase (TPO) is a glycosylated
hemoprotein that plays a key role in thyroid hormone synthesis. We
previously showed that in CHO cells expressing human TPO (hTPO) only
2% of synthesized hTPO reaches the cell surface. Herein, we
investigated the role of heme moiety insertion in the exit of hTPO from
the endoplasmic reticulum. Peroxidase activity at the cell surface and
cell surface expression of hTPO were decreased by ~30 and ~80%,
respectively, with succinyl acetone, an inhibitor of heme biosynthesis,
and were increased by 20% with holotransferrin and aminolevulinic acid, precursors of heme biosynthesis. Results were similar with holotransferrin plus aminolevulinic acid or hemin, but hemin increased cell surface activity more efficiently (+120%) relative to the control. It had been suggested (DePillis, G., Ozaki, S., Kuo, J. M., Maltby, D. A., and Ortiz de Montellano, P. R. (1997)
J. Biol. Chem. 272, 8857-8960) that covalent
attachment of heme to mammalian peroxidases could be an
H2O2-dependent autocatalytic processing. In our study, heme associated intracellularly with hTPO,
and we hypothesized that there was insufficient exposure to
H2O2 in Chinese hamster ovary cells before hTPO
reached the cell surface. After a 10-min incubation, 10 µM H2O2 led to a 65% increase in
cell surface activity. In contrast, in thyroid cells, H2O2 was synthesized at the apical cell surface
and allowed covalent attachment of heme. Two-day incubation of
primocultures of thyroid cells with catalase led to a 30% decrease in
TPO activity at the cell surface. In conclusion, we provide compelling
evidence for an essential role of 1) heme incorporation in the
intracellular trafficking of hTPO and of 2)
H2O2 generated at the apical pole of thyroid
cells in the autocatalytic covalent heme binding to the TPO molecule.
 |
INTRODUCTION |
Thyroperoxidase (TPO)1
is a membrane-bound, glycosylated hemoprotein that plays a key role in
the biosynthesis of thyroid hormones. It catalyzes the iodination of
thyroglobulin and the coupling of some of the iodotyrosyl residues to
produce thyroxine and 3,3',5-triiodothyronine (1-3). Kimura et
al. (4) proposed that His407 or His414 is
the proximal heme binding site. On the other hand, His586
may be a critical residue for the enzymatic activity of the protein by
being the distal heme binding site (5). Recently, Taurog and Wall (6)
proposed His239 as the proximal binding site and
His494 as the distal binding site.
During the past 40 years, the nature of the heme prosthetic group of
TPO has been debated. Hossaya and Morrison (7), Krinsky and Alexander
(8), and Ohtaki et al. (9) reported that the prosthetic
group of TPO might be a ferriprotoporphyrin IX. Rawitch et
al. (2) showed significant differences between the pyridine hemochromogene of TPO and horseradish peroxidase, suggesting that the
heme in TPO is not ferriprotoporphyrin IX. TPO, lactoperoxidase (LPO),
myeloperoxidase (MPO), saliva peroxidase, eosinoperoxidase, and
intestinal peroxidase belong to the mammalian peroxidase family. These
proteins share related protein primary structure (10, 11) and are alike
in spectral properties. Furthermore, their prosthetic heme moieties are
not readily extracted by conventional approaches. Anderson et
al. (12) considered that spectral similarities between LPO and
other mammalian peroxidases indicated similar prosthetic heme moieties
and a covalent attachment of the heme group to the protein. They
suggested that the heme moiety of TPO is probably a type l heme, like
LPO. This heme is covalently linked to the protein through ester bonds
that link aspartate and glutamate residues (conserved in MPO, LPO, and
TPO) and the hydroxymethyl group of heme. Heme is inserted into the
protein certainly in the endoplasmic reticulum, as for MPO (13). This
insertion seems necessary for the proteolytic processing leading to the
formation of an enzymatically active mature MPO and for the exit of MPO from the ER and its subsequent targeting to the lysosomes (14).
We had proposed a model for the folding, degradation, and intracellular
trafficking of human TPO (hTPO) in CHO cells (15). We showed that after
synthesis only 2% of the hTPO molecules exited from the ER and reached
the cell surface. The remaining 98% are more or less rapidly degraded
depending on their folding state.
In the present work, we looked into the role of the heme moiety
insertion in the exit of hTPO from the ER. We also investigated a
possible H2O2-dependent
autocatalytic modification of heme, responsible for its subsequent
covalent attachment to TPO, as described by the group of Montellano
(16) for LPO. Effectively in thyroid cells,
H2O2 is synthesized at the apical cell surface level and then could be implicated in this covalent linking of the heme
prosthetic group to TPO.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Sigma supplied the following: succinyl acetone
(SA), hemin, aminolevulinic acid (ALA), holotransferrin (FeTf),
catalase, and BT2cAMP. Penicillin and streptomycin were
from Life Technologies, Inc. Fetal bovine serum (FBS) and protease
inhibitor mixture tablets (Complete) were from Boehringer Mannheim (Le
Meylan, France). Na125I was obtained from Amersham
Pharmacia Biotech (Les Ullis, France). Expre35S35S protein labeling mix (referred to
as "35S-(Met + Cys)") and
14C-aminolevulinic acid were from NEN Life Science (Paris,
France). Streptavidin-agarose and sulfosuccinimidyl-2-(biotinamide)
ethyl-1,3'-dithiopropionate (NHS-SS-biotin) were from Pierce. Protein
A-Sepharose 4B was from Zymed Laboratories Inc. (San
Francisco, CA). Monoclonal antibodies (mAbs) raised against hTPO
were given by J. Ruf.
Reagent Preparations--
Stock solutions of hemin (2 mM) in phosphate-buffered saline (PBS) were prepared
immediately before experiments and dissolved by the addition of 0.15 M NaOH to obtain a pH range between 7.0 and 7.5. Succinyl
acetone (25 mM in PBS), holotransferrin (1 mg/ml in PBS),
and catalase (1% in PBS) solutions were freshly prepared for each
experiment and filter-sterilized before the addition in culture medium.
Cell Cultures--
As described (15), full-length 3060-kilobase
pair human TPO cDNA (kindly provided by B. Rapoport) was cloned
into the eukaryotic transfer vector pcDNA3, and after stable
transfection a CHO cell line (CHO-hTPO cells) expressing hTPO was
obtained. The cells were cultured in Ham's F-12 medium supplemented
with 10% FBS, penicillin (100 IU/ml), and streptomycin (100 µg/ml),
and expression of hTPO was stimulated 48 h before
experiments with sodium butyrate (5 mM).
Primocultures of porcine thyroid cells were performed as described
(17). Porcine thyroid cells were isolated by discontinuous trypsin-EGTA
treatment and suspended in Dulbecco's modified Eagle's medium. The
cells were seeded in 9.6-cm2 dishes and incubated at
36 °C in a water-saturated atmosphere of 5% CO2, 95%
air. Culture media were changed every 2-3 days. After 3-5 days, a
monolayer was obtained, and the cells were stimulated with
10
4 M Bt2cAMP for 5 days.
Cell Surface Biotinylation--
Confluent cells were
radiolabeled for up to 6 days with 100 µCi/ml 35S-(Met + Cys) in cysteine- and methionine-free Dulbecco's modified Eagle's
medium supplemented with 10% FBS, and 10 mM sodium
butyrate. Cell monolayers were then washed twice with ice-cold PBS, pH
8.0, supplemented with 1 mM CaCl2 and 1 mM MgCl2 (PBS-CM) before the cross-linker
(NHS-SS-biotin) was added at 0.5 mg/ml in PBS-CM for 20 min on ice.
Cross-linker was removed, and the same operation was repeated once.
Then the medium was removed, and the remaining reactive NHS-SS-biotin
was blocked by the addition of 50 mM NH4Cl in PBS-CM. The
cells were then scraped in 600 µl of extraction buffer containing 50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1% Triton X-100, 0.3% deoxycholic acid, and protease inhibitor mixture. The
cells were then tumbled for 20 min at 4 °C with vortexing every 2 min and centrifuged for 3 min at 10,000 × g. The
supernatant was incubated for 2 h with (mAb 47 + mAb 15)-protein
A-Sepharose complexes. These mAbs had been complexed with protein A by
incubation overnight at 4 °C. Immune complexes were retrieved by a
brief centrifugation (10,000 × g, 10 s) and washed four
times with 1 ml of hTPO extraction buffer. The immunoprecipitated hTPO
was separated from the protein A-Sepharose pellet by heating 5 min at
100 °C after the addition of 10 µl of 10% SDS and 500 µl of hTPO extraction buffer. The suspension was diluted with 500 µl of
hTPO extraction buffer and centrifuged for 3 min at 10,000 × g. The supernatant was incubated 2 h with
avidin-agarose at room temperature. Biotinylated surface hTPO and
intracellular hTPO were separated by centrifugation (10 s, 10,000 × g). The beads were washed four times with hTPO extraction
buffer and once with PBS, resuspended in Laemmli sample buffer (18),
and then boiled for 5 min. The totality of supernatant corresponding to the cell surface fraction and only
of the supernatant
corresponding to the intracellular fraction were prepared for SDS-PAGE
analysis. The radioactivity was visualized and quantified by a phosphor
imager (Fuji BAS 1000).
Heme Binding to hTPO--
CHO-hTPO cells were incubated in
Ham's F-12 medium supplemented with 10 mM sodium butyrate,
1% FBS, and 10 µCi of [14C]aminolevulinic acid for
48 h. After 48 h, intracellular and cell surface radiolabeled
hTPO molecules were separated by cell surface biotinylation,
immunoprecipitated, and subjected to SDS-PAGE as described above.
Treatment of 14C-Heme-labeled hTPO by
Acetone/HCl--
14C-Heme-labeled hTPO was treated with
acetone/HCl as described previously for other hemoproteins (19) with
small modifications. CHO-hTPO cells were labeled with
[14C]aminolevulinic acid as described above. The
14C-heme-labeled hTPO was immunoprecipitated and separated
from protein A-Sepharose pellet by heating 5 min at 100 °C after the addition of 10 µl of 10% SDS. Then 40 µl of hTPO extraction buffer was added, and the suspension was centrifuged (3 min, 10,000 × g). The supernatant was supplemented with 1 ml of acetone
containing 0.2% HCl (12 N) and 20 µg of bovine serum
albumin and incubated for 30 min at 4 °C. After centrifugation (10 min, 10,000 × g), the supernatant was discarded and
the pellet was dried using a Speed Vac. This pellet was dissolved in
100 µl of Laemmli buffer, heated 5 min at 100 °C, and subjected to
SDS-PAGE.
Human TPO Enzymatic Activity--
Enzymatic activity was
investigated as described by Neary et al. (20) with slight
modifications. The medium was removed, and cells were washed twice with
ice-cold PBS buffer. The incubation mixture contained bovine serum
albumin (5 mg/ml in PBS) and Na125I (106
cpm/ml). The reaction was initiated by the addition of
H2O2 to obtain a final concentration of 0.5 mM. Cells were incubated for 20 min at room temperature. At
the end of this incubation time, the medium was transferred to cold
reaction tubes, and the cell surface was washed once with 0.5 ml of
PBS. Then 1 ml of ice-cold 20% (w/v) trichloracetic acid supplemented
with 10
4 M KI was added to each tube. After
20 min at 4 °C, the suspension was centrifuged (2000 × g, 6 min). The supernatant was discarded, and the
acid-insoluble iodinated material obtained was washed three times with
2 ml of 10% trichloracetic acid. The radioactivity remaining in the
pellet was counted.
Determination of Total Porphyrin Concentration--
Total
porphyrin concentration was determined fluorometrically as described by
Sassa (21). This method is based on the conversion of the heme moiety
of the protein into its fluorescent porphyrin derivative by the removal
of heme under acidic reducing conditions.
 |
RESULTS AND DISCUSSION |
Our previous data (15) revealed that in CHO cells, only 2% of
hTPO molecules reach the cell surface, and the rest (98%) are
degraded. To determine if the heme moiety had to be inserted into hTPO
for its exit from the ER, we first used SA, a specific inhibitor of
5-aminolevulinic dehydratase, which catalyzes the formation of
porpholibinogen from 5-aminolevulinate in the heme biosynthesis pathway
(22, 23). CHO-hTPO cells were incubated for 16 h, 3 days, or 6 days with or without 250 µM SA. CHO cells tolerated SA
well at this concentration for up to 6 days with no change in cell
morphology. In a first set of experiments, we determined the effects of
SA on the total porphyrin concentration in the cells as described by
Sassa (Ref. 21; see "Experimental Procedures"). Compared with
control, with SA the total porphyrin concentration decreased by 20, 50, and 50% for incubation times of 16 h, 3 days, and 6 days,
respectively. Then we studied the effect of SA on hTPO enzymatic
activity and delivery at the cell surface (Fig.
1). After 16 h of incubation with SA
the delivery of hTPO at the cell surface decreased by 37%, and the
activity was decreased by 79%. After 3 and 6 days, the cell surface
delivery decreased by 25 and 35%, and the activity decreased by 68 and 92%, respectively. Note that whatever the incubation time with SA, the
decrease in delivery at the cell surface remains stable (about 30%)
and is similar to or a little lower than the decrease in total
porphyrin synthesis and that the decrease in hTPO activity is higher
(68 and 92%) than the decrease in total porphyrin synthesis (20-50%). To confirm that SA impaired only heme biosynthesis without affecting intracellular transport of protein(s) not containing heme, we
measured delivery at the cell surface of
Na+-K+-ATPase. The trafficking of
Na+-K+-ATPase was unaffected by SA (data not
shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of succinyl acetone on the activity
and delivery of hTPO at the cell surface. A, CHO-hTPO
cells were incubated for 16 h, 3 days, or 6 days with ( ) or
without ( ) 250 µM SA. At these times, cell surface
activity was measured and expressed as a percentage of control at 6 days. B, CHO-hTPO cells were incubated for 16 h, 3 days, or 6 days with ( ) or without ( ) 250 µM SA and
with 35S-(Met + Cys). After cell surface biotinylation and
hTPO immunoprecipitation, the percentage of hTPO at the cell surface
was determined. Statistically significant differences versus
control were as follows: p < 0.05 ( ).
|
|
To verify that the concentration of heme in CHO-hTPO cells is not a
limiting factor (that could explain the low percentage of hTPO reaching
the plasma membrane) we enhanced heme biosynthesis pathway by adding to
the culture medium ALA, FeTf, or hemin for 48 h (Fig.
2). For cell surface biotinylation
assays, cells were incubated for 48 h with 35S-(Met + Cys) with or without those components. In cell surface activity
experiments, a negative control was performed with
methylmercaptoimidazole. Adding ALA or FeTf to the culture medium had
no effect on activity and delivery at the cell surface, contrary to the
association ALA plus FeTf and hemin, which increased delivery at the
cell surface by 20% (Fig. 2B) and the enzymatic activity by
20% for ALA plus FeTf and 120% for hemin (Fig. 2A). Note
that a 48-h treatment with ALA plus FeTf leads to a 10-fold higher
concentration of total porphyrin in the cells than in control. The
moderate increase (20%) in the delivery at the cell surface with ALA
plus FeTf or with hemin shows that heme biosynthesis in CHO cells is
only slightly limiting. Together with the SA data (Fig. 1), the first
conclusion is that the insertion of heme is important for hTPO
intracellular trafficking and delivery at the cell surface. We found
that SA has no noticeable effect on hTPO stability because the
half-life of hTPO remained unchanged with or without SA (data not
shown). Concerning the importance of insertion of heme in other
proteins for the exit from the ER, similar results have been
obtained with MPO (13). In addition, heme insertion into cytochrome
b558 plays an important role in its subunit
assembly (24).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of ALA (100 µM), holotransferrin (20 µg/ml), and hemin (20 µM) on activity and delivery of hTPO at
the cell surface. A, CHO-hTPO cells were incubated with
or without one of these three compounds or with ALA plus
holotransferrin for 48 h, and then hTPO cell surface activity was
measured. B, CHO-hTPO cells were incubated as in
A, but the cell culture medium was supplemented with
35S-(Met + Cys). After cell surface biotinylation and
immunoprecipitation, the percentage of hTPO at the cell surface was
determined. Statistically significant differences versus
control were as follows: p < 0.05 ( ).
|
|
Hemin increased the quantity of hTPO at the cell surface level by 20%
and increased the cell surface activity by 120%. These values suggest
that some of the hTPO molecules at the cell surface are inactive
because they lack heme. That hTPO binds hemin added in culture medium
agrees with the conclusion of Fan et al. (25) and Guo
et al. (26). It could be hypothesized that heme associates with hTPO in the ER and that part of this heme is dissociated from the
enzyme after hTPO exits from the ER, especially at the cell surface.
In mammalian peroxidases, the heme moiety is covalently linked to the
protein backbone (11, 12). As mentioned above, TPO, LPO, MPO, and EPO
belong to the mammalian peroxidase family. Spectral analysis (12)
indicated that the heme of TPO could be a type l heme like LPO.
Moreover, Kooter et al. (27) also indicated that the
prosthetic group of mammalian peroxidase was
1,5-dihydroxymethyl-modified heme b attached by covalent bonds to the
protein. For type l and m (heme moiety of MPO) heme, the heme moiety is
covalently linked to the protein through two ester bonds that link
aspartate and glutamate residues (conserved in all mammalian
peroxidases) of the protein with the heme hydroxymethyl groups. For
MPO, there is an additional vinyl sulfonium link involving a methionine
residue (not conserved in TPO and LPO) of the protein and the 2-vinyl moiety of the heme. Total dissociation of noncovalently bound heme from
protein is classically obtained using acidic treatment. However, for
some hemoproteins, SDS treatment leads to heme removal (19). To see if
heme was covalently linked to hTPO in CHO-hTPO cells and if acidic and
SDS treatment provided the same results, we incubated CHO-hTPO cells in
the presence of [14C]ALA for 48 h. After
immunoprecipitation, the 14C-heme-labeled hTPO was treated
by acetone/HCl or SDS/2-mercaptoethanol and then analyzed by SDS-PAGE.
The result obtained is showed in Fig. 3.
After quantification by phosphor imaging no difference was found
between the two treatments. Therefore, we can assume that in CHO-hTPO
cells heme can covalently link to hTPO and that after denaturation by
SDS and reduction only covalently bound heme remains associated with
this protein.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 3.
Treatment of 14C-heme-labeled
hTPO with SDS/2-mercaptoethanol (A) or with
acetone/HCl (B). CHO-hTPO cells were incubated
for 48 h with [14C]ALA, and then hTPO was
immunoprecipitated and treated either by SDS and 2-mercaptoethanol or
by acetone and HCl.
|
|
Recently, DePillis et al. (16) proposed a mechanism for
autocatalytic heme modification and covalent binding in LPO and other
mammalian peroxidases. In the presence of H2O2,
heme could be autocatalytically modified and could subsequently be
linked covalently to the protein. We hypothesize that in CHO cells
there is an insufficient exposure to H2O2
before hTPO reaches the cell surface. This would explain the
dissociation of the heme from the protein after its exit from the ER.
In most cells, H2O2 availability in the
intracellular compartments is controlled by cytosolic
selenium-containing GSH peroxidase, peroxisomal catalase, or PRX
enzymes (28, 29). To test the possibility that the heme moiety of TPO
could be covalently linked to the protein through an autocatalytic
process as for LPO (16), we incubated CHO-hTPO cells with or without 10 µM H2O2 for 10 min or 20 µM hemin for 10 min or 48 h before assaying hTPO
activity (Fig. 4). A 10-min exposure to
10 µM H2O2 led to a 65% increase
in cell surface activity. This great increase is similar to that
obtained with a 10-min treatment with hemin, indicating that hTPO
activity increases in parallel with the extent of covalent heme
binding. Because of the short exposure time to
H2O2 (10 min), this compound can act only on
the activity of the hTPO molecules at the cell surface. To check if an
increase in covalent heme binding and then in activity could be
obtained by extending the incubation time with
H2O2, we incubated CHO-hTPO cells with or without 10 µM H2O2 for 24 h.
Enzymatic activity and delivery of hTPO at the cell surface were
measured (Fig. 5). With
H2O2 activity increased slightly (10%) (Fig.
5A), delivery at the cell surface decreased by 30% (Fig.
5B) because protein synthesis was inhibited by
H2O2. Hence, long exposure to
H2O2 does not notably increase the enzymatic
activity. This may be due to a toxic effect of
H2O2 on the cells and/or an impossibility of
maintaining a constant concentration of H2O2 in
the culture medium. However, as shown in Figs. 4 and 5, the hTPO at the
cell surface may have 1) a noncovalently linked heme that can react
with exogenous H2O2 and then increase activity, 2) no heme
(thus explaining the results with hemin), or 3) a covalently linked
heme (Fig. 6A). To determine
if covalent linking occurs intracellularly and if cell surface hTPO has
a covalently linked heme, we investigated the incorporation of
[14C]ALA (a radiolabeled precursor of heme biosynthesis)
into hTPO in the intracellular compartments or at the cell surface by
using a cell surface biotinylation technique. After immunoprecipitation of the protein with a couple of mAbs (15), analysis was done by
SDS-PAGE after denaturation of the protein with SDS and reduction with
2-mercaptoethanol (Fig. 7). Depending on
the experiments, 50-70% of heme was recovered covalently linked to
hTPO in the intracellular compartment, and 30-50% was recovered at
the cell surface level. It was not possible to determine the relative
quantity of the hTPO bearing or not bearing heme and of the hTPO with a heme covalently linked.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of H2O2,
hemin, or the association H2O2 plus hemin on
the cell surface hTPO activity. hTPO cells were incubated with or
without H2O2 (10 µM) and with or
without hemin (20 µM) before assaying hTPO activity.
Statistically significant differences versus control were as
follows: p < 0.05 ( ); p < 0.01 ( ); p < 0.001 (  ).
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of a 24-h incubation with
H2O2 on the activity and delivery of hTPO at
the cell surface. A, CHO-hTPO cells were cultured with
or without H2O2 (10 µM) for
24 h before hTPO activity was assayed. B, CHO-hTPO
cells were incubated as in A, but the cell culture medium
was supplemented with 35S-(Met + Cys). After cell surface
biotinylation and hTPO immunoprecipitation, the percentage of hTPO at
the cell surface level was determined. Specific activity of hTPO at the
cell surface after incubation for 24 h with or without
H2O2 was determined. Statistically significant
differences versus control were as follows:
p < 0.01 ( ).
|
|

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 7.
Incorporation of [14C]ALA into
hTPO present at the intracellular level or at the cell surface.
Cells were incubated for 48 h with [14C]ALA. After
cell surface biotinylation and immunoprecipitation,
14C-hTPO in the intracellular compartments or at the cell
surface was analyzed by SDS-PAGE.
|
|
To confirm that covalent attachment of heme to hTPO required
H2O2, we investigated the incorporation of
[14C]ALA into the hTPO present at the cell surface with
or without treatment with H2O2 for 10 min (Fig.
8). Depending on the experiment, we
detected between 2- and 5-fold more [14C]ALA associated
with hTPO when the cells were treated for 10 min with 10 µM H2O2 before cell surface
biotinylation. Furthermore, this result also confirms that the increase
in cell activity observed at the cell surface level in the presence of
H2O2 (Fig. 4) results from a direct effect on
the hTPO and not, for example, from a removal of an inhibitory ligand
linked to this enzyme.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of H2O2 on the
amount of 14C-heme covalently linked to hTPO at the cell
surface. CHO-hTPO cells were treated for 48 h with
[14C]ALA and with or without 10 µM
H2O2, 10 min before the cell biotinylation
assay. 14C-hTPO at the cell surface was analyzed by
SDS-PAGE.
|
|
Intracellular H2O2 leading to covalent heme
binding is probably a by-product of electron transfer reactions.
However, in contrast to CHO cells, thyroid cells have an additional
physiological production of H2O2 that is
involved in the iodination reactions at the apical cell surface and in
thyroid hormone synthesis. This H2O2 is
generated by an NADPH oxidase system in the apical membrane (30). Thus, H2O2 synthesized at the apical cell surface of
thyroid cells might contribute to covalent attachment of heme (Fig.
6B). To verify this, we prepared primocultures of porcine
thyroid cells and examined the effects of a 10-min incubation with 10 µM H2O2 and a 48-h treatment with
20 µM hemin or 0.01% catalase. In these culture conditions, thyroid cells form monolayers with an apical pole oriented
toward the culture medium (17). Hemin increased hTPO activity by 30%
(Fig. 9), which is less than the
percentage with CHO cells, because most heme is covalently linked to
hTPO at the cell surface because of the production of
H2O2 by thyroid cells. This was confirmed by
the absence of effect of H2O2 added for 10 min
in the culture medium (Fig. 9). However, the increase with hemin shows
that some hTPO at the cell surface does not bear heme. Consequently,
some hTPO may reach the cell surface without heme. The increase with
hemin may also be attributed to by the type of culture used,
primoculture in monolayer. H2O2 synthesized at the apical cell surface level is likely to be diluted into the culture
medium, which would allow covalent heme binding in a less efficient way
than in thyroid follicles.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of H2O2,
hemin, and catalase on cell surface hTPO activity in primoculture of
porcine thyroid cells. Thyroid monolayer cells were incubated for
48 h with or without hemin or catalase (0.01%).
H2O2 (10 µM) was added 10 min
before hTPO cell surface activity was assayed. Statistically
significant differences versus control were as follows:
p < 0.05 ( ); p < 0.01 ( );
p < 0.001 (  ).
|
|
These results were confirmed by incubating cells with catalase for
48 h (with the addition of enzyme after 24 h), which led to a
30% decrease in hTPO activity at the surface of thyroid cells. We can
assume the catalase in the culture medium is unable to pass the plasma
membrane. Its H2O2 degradation action is then restricted to the cell surface. Catalase addition does not cause a
greater inhibition of hTPO activity 1) because some heme can be linked
covalently to hTPO intracellularly and 2) because of the half-life of
hTPO at the cell surface level, and covalently bound heme remained with
hTPO molecules synthesized before catalase addition.
This study shows that heme insertion into hTPO is important for the
delivery of protein at the cell surface and that the heme moiety is
covalently bound to hTPO through the
H2O2-dependent autocatalytic
process as for LPO (16). Also, we found a new role for
H2O2 generated at the apical membrane of
thyroid cells besides its classical role in TPO-catalyzed iodotyrosines
and thyroid hormone formation; apical H2O2 helps to
stabilize TPO into an active form through its contribution in
autocatalytic covalent attachment of heme to TPO.
 |
ACKNOWLEDGEMENTS |
We thank B. Rapoport for providing
full-length hTPO, J. Ruf for providing hTPO mAb, O. Chabaud for
providing porcine thyroid cells, M. Ferrand for helpful discussion, and
A. Giraud for reading the manuscript.
 |
FOOTNOTES |
*
This work was supported by INSERM (U38) and by the
Association pour la Recherche sur le Cancer.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by Association pour le Developpement des Recherches
Biologiques et Médicales.
§
To whom correspondence should be addressed. Tel.: 33-4-91-32-43-77;
Fax: 33-4-91-79-77-74; E-mail:
Jean-Louis.Franc{at}medecine.univmrs.fr.
 |
ABBREVIATIONS |
The abbreviations used are:
TPO, thyroperoxidase;
hTPO, human TPO;
CHO, Chinese hamster ovary;
mAb, monoclonal antibody;
ER, endoplasmic reticulum;
LPO, lactoperoxidase;
MPO, myeloperoxidase;
SA, succinyl acetone;
ALA, aminolevulinic acid;
FBS, fetal bovine serum;
NHS-SS-biotin, sulfosuccinimidyl-2-
(biotinamide) ethyl-1,3'-dithiopropionate;
PBS, phosphate-buffered
saline;
FeTf, holotransferrin;
PAGE, polyacrylamide gel
electrophoresis.
 |
REFERENCES |
-
Nunez, J.,
and Pommier, J.
(1982)
Vitam. Horm.
39,
175-229[Medline]
[Order article via Infotrieve]
-
Rawitch, A. B.,
Taurog, A.,
Chernoff, S. B.,
and Dorris, M. L.
(1979)
Arch. Biochem. Biophys.
194,
244-257[Medline]
[Order article via Infotrieve]
-
Taurog, A.
(1991)
in
The Thyroid (Braverman, L. E., and Utiger, R. D., eds), pp. 51-97, J. B. Lippincott Co., Philadelphia
-
Kimura, S.,
and Ikeda-Saito.
(1988)
Proteins Struct. Funct. Genet.
3,
113-120[Medline]
[Order article via Infotrieve]
-
Banga, J. P.,
Mahadevan, D.,
Barton, G. J.,
Sutton, B. J.,
Saldanha, J. W.,
Odell, E.,
and McGregor, A. M.
(1990)
FEBS Lett.
266,
133-141[CrossRef][Medline]
[Order article via Infotrieve]
-
Taurog, A.,
and Wall, M.
(1998)
Thyroid
8,
185-191[Medline]
[Order article via Infotrieve]
-
Hossaya, T.,
and Morrison, M.
(1967)
J. Biol. Chem.
242,
2828-2836[Abstract/Free Full Text]
-
Krinsky, M. M.,
and Alexander, N. M.
(1971)
J. Biol. Chem.
246,
4755-4758[Abstract/Free Full Text]
-
Ohtaki, S.,
Nakagawa, H.,
Nakamura, S.,
Nakamura, M.,
and Yamazaki, I.
(1985)
J. Biol. Chem.
260,
441-448[Abstract/Free Full Text]
-
Cals, M. M.,
Mailliart, P.,
Brignon, G.,
Anglade, P.,
and Dumas, B. R.
(1991)
Eur. J. Biochem.
198,
733-739[Abstract]
-
Fenna, R.,
and Zeng, J.
(1995)
Arch. Biochem. Biophys.
316,
653-656[CrossRef][Medline]
[Order article via Infotrieve]
-
Andersson, L. A.,
Bylkas, S.,
and Wilson, A. E.
(1996)
J. Biol. Chem.
271,
3406-3412[Abstract/Free Full Text]
-
Arnljots, K.,
and Olsson, I.
(1987)
J. Biol. Chem.
262,
10430-10433[Abstract/Free Full Text]
-
Nauseef, W.,
McCormick, S.,
and Yi, H.
(1992)
Blood
80,
2622-2633[Abstract]
-
Fayadat, L.,
Niccoli-Sire, P.,
Lanet, J.,
and Franc, J. L.
(1998)
Endocrinology
139,
4277-4285[Abstract/Free Full Text]
-
DePillis, G.,
Ozaki, S.,
Kuo, J. M.,
Maltby, D. A.,
and Ortiz de Montellano, P. R.
(1997)
J. Biol. Chem.
272,
8857-8860[Abstract/Free Full Text]
-
Chambard, M.,
Verrier, B.,
Gabrion, J.,
and Mauchamp, J.
(1983)
J. Cell Biol.
96,
1172-1177[Abstract]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685[Medline]
[Order article via Infotrieve]
-
Kuras, R.,
de Vitry, C.,
Choquet, Y.,
Girard-Bascou, J.,
Culler, D.,
Büschlen, S.,
Merchant, S.,
and Wollman, F. A.
(1997)
J. Biol. Chem.
272,
32427-32435[Abstract/Free Full Text]
-
Neary, J. T.,
Soodak, M.,
and Maloof, F.
(1984)
Methods Enzymol.
107,
445-475[Medline]
[Order article via Infotrieve]
-
Sassa, S.
(1976)
J. Exp. Med.
143,
305-315[Abstract]
-
Ponka, P.
(1997)
Blood
89,
1-25[Free Full Text]
-
Richardson, D. R.,
Ponka, P.,
and Vyoral, D.
(1996)
Blood
87,
3477-3488[Abstract/Free Full Text]
-
Yu, L.,
Zhen, L.,
and Dinauer, M. C.
(1997)
J. Biol. Chem.
272,
27288-27294[Abstract/Free Full Text]
-
Fan, J. L.,
Patibandla, S.,
Kimura, S.,
Rao, T.,
Desai, R. K.,
Seetharamaiah, G. S.,
Kurosky, A.,
and Prabhakar, B. S.
(1996)
J. Autoimmun.
9,
529-536[CrossRef][Medline]
[Order article via Infotrieve]
-
Guo, J.,
McLachlan, S.,
Hutchison, S.,
and Rapoport, B.
(1998)
Endocrinology
139,
999-1005[Abstract/Free Full Text]
-
Kooter, I. M.,
Pierik, A. J.,
Merkx, M.,
Averill, B. A.,
Moguilevsky, N.,
Bollen, A.,
and Wever, R.
(1997)
J. Am. Chem. Soc.
119,
11542-11543[CrossRef]
-
Halliwell, B.,
and Gutteridge, J. M. C.
(1991)
Free Radicals in Biology and Medicine, pp. 86-187, Clarendon Press, Oxford
-
Kang, S. W.,
Chae, H. Z.,
Seo, M. S.,
Kim, K.,
Baines, I. C.,
and Rhee, S. G.
(1998)
J. Biol. Chem.
273,
6297-6302[Abstract/Free Full Text]
-
Gorin, Y.,
Ohayon, R.,
Carvalho, D. P.,
Dème, D.,
Leseney, A. M.,
Kaniewski, J.,
Pommier, J.,
Virion, A.,
and Dupuy, C.
(1996)
Eur. J. Biochem.
240,
807-814[Abstract]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.